UK Annual Report and Notice of AGM
14 mai 2019 12h30 HE
|
Summit Therapeutics plc
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Publication of UK Annual Report and Notice of Annual General Meeting Oxford, UK, and Cambridge, MA, US, 14 May 2019 - Summit Therapeutics plc...
Block Listing Interim Review
29 avr. 2019 07h30 HE
|
Summit Therapeutics plc
BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 29 April 2019 Name of applicant:Summit Therapeutics plcName of scheme:2005 EMI...
Exercise of Restricted Stock Units
24 avr. 2019 11h20 HE
|
Summit Therapeutics plc
Summit Therapeutics plc (‘Summit’ or the ’Company’) Exercise of Restricted Stock Units and Total Voting Rights Oxford, UK, and Cambridge, MA, US, 24 April 2019 – Summit Therapeutics plc (NASDAQ:...
Filing of Annual Report on Form 20-F
29 mars 2019 07h15 HE
|
Summit Therapeutics plc
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics Files US Annual Report on Form 20-F Oxford, UK, and Cambridge, MA, US, 29 March 2019 – Summit Therapeutics plc (NASDAQ:...
Holding(s) in Company
15 janv. 2019 12h45 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Award of Restricted Stock Units
14 janv. 2019 07h00 HE
|
Summit Therapeutics plc
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Award of Restricted Stock Units Oxford, UK, and Cambridge, MA, US, 14 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a...
Completion of $25 million subscription
10 janv. 2019 07h00 HE
|
Summit Therapeutics plc
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Completion of $25 million subscription Oxford, UK, and Cambridge, MA, US, 10 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ:...
Completion of $25 million Subscription
10 janv. 2019 02h00 HE
|
Summit Therapeutics plc
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Completion of $25 million subscription Oxford, UK, and Cambridge, MA, US, 10 January 2019 - Summit Therapeutics (AIM: SUMM,...
Result of General Meeting
04 janv. 2019 07h30 HE
|
Summit Therapeutics plc
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Result of General Meeting Oxford, UK, and Cambridge, MA, US, 4 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a...
Holding(s) in Company
02 janv. 2019 04h40 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...